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We report serologic and molecular evidence of acute,
febrile illness associated with Rickettsia conorii in 3 male
Yorkshire terriers from Sicily (Italy).
R
ickettsia conorii, transmitted by Ripicephalus san-
guineus, causes Mediterranean spotted fever (MSF) in
humans in Mediterranean countries, Sub Saharan Africa
and Asia (1). Rickettsia spp. seroprevalence in dogs is high
(26%–60%) in disease-endemic regions, and proximity to
seroreactive dogs is a risk factor for MSF in humans (2,3).
Recent studies reported the detection of Rickettsia DNAin
the blood of European dogs (4,5). However, evidence that
R. conorii infection causes illness in dogs is lacking
(2,3,6). Illness has been associated with R. conorii natural
infection in only 2 dogs since human MSF was described
in 1932 (6). Moreover, the only clinical signs observed in
experimentally infected dogs were pain, erythema, and
edema at the injection site; and regional lymphadenopathy
(6). We report infection with R. conorii ssp. conorii in 3
acutely ill, febrile Yorkshire terrier dogs, supported by
PCR, DNA sequencing, and seroconversion.
The Study
Between May and September 2005, three unrelated
intact male Yorkshire terriers with a mean age of 4.3 years
from Catania, Sicily, were brought to a local veterinarian;
the dogs had the following histories: anorexia and lethargy
of 2 days’ duration (dog 1); anorexia, lethargy, and inter-
mittent lameness of a few days’duration (dog 2); and inter-
mittent vomiting, anorexia, and lethargy of a few days’
duration (dog 3). Despite living mostly indoors, all 3 dogs
had a recent history of tick exposure. All dogs had received
current vaccination histories and had no history of serious
illness. Results of the physical examination and hemato-
logic, biochemical, and serum electrophoresis abnormali-
ties at the time of onset of clinical signs and after 1 month
(dogs 2 and 3) and 2 months (dog 1) of follow-up are pro-
vided in Table 1. Treatments instituted for all 3 dogs at
onset of illness are described in Table 1.
EDTA-blood and serum samples were obtained by the
attending veterinarian at the time of clinical assessment
(before treatment), then 1 week later and 1 month (dogs 2
and 3) or 2 months later (dog 1). DNA extraction was per-
formed from whole blood samples (5,7). A quantitative
PCR (qPCR) for detection of Rickettsia spp., Anaplasma
phagocytophilum, Ehrlichia canis, and Leishmania infan-
tum in DNA samples was performed by using a Light
Cycler (Roche, Mannheim, Germany). PCR amplification
was carried out with Rickettsia (Rr-prim3 5′-GAAACC
GAAAGAGAATCTTCCGAT-3′ and Rr-prim4 5′-TCC
TAGTGTAGAGGTGAAATTCTTA-3′ [8]),  E. canis,  A.
phagocytophilum (fragment of 16S rRNA gene), and L.
infantum LCSet primers and probes following manufac-
turer’s instructions (TIB Molbiol, Centro Biotecnologie
Avanzate, Genova, Italy) (5,7). Conventional Babesia
genus PCR was performed (9). Borrelia burgdorferi sensu
lato qPCR was performed by a commercial laboratory
(www.scanelis.com). PCR results for all infectious agents
listed above, with the exception of Rickettsia, were nega-
tive in all dogs.
PCRs for Rickettsia that use the outer membrane pro-
tein A (ompA) gene to amplify 632 bp (10) and 212 bp
(107F 5′-GCTTTATTCACCACCTCAAC-3′ and 299R 5′-
TRATCACCACCGTAAGTAAAT-3′) (7) amplicons were
performed. For dog 1, a 632-bp amplicon was cloned by
using the TOPO TA Cloning (Invitrogen, Carlsbad, CA,
USA) and sequenced (GenBank accession nos.
DQ518245) (7). For dogs 2 and 3, a 212-bp amplicon was
subjected to direct sequencing (accession no. DQ518246,
DQ518247) (7). PCR results are summarized in Table 1.
Consensus sequences were aligned [(BIOEDIT version
7.0 (ClustalW)] with known sequences in GenBank using
the basic local alignment search tool (BLAST; available
from http://www.ncbi.nlm.nih.gov/BLAST/). The sequence
obtained from all 3 dogs was 100% homologous to a por-
tion of the complete genome sequence corresponding to
the ompA gene from R. conorii (Malish 7, accession no.
AE008674).
Immunofluorescent assays to detect antibodies to R.
rickettsii, R. conorii, B. burgdorferi sensu stricto, E. canis,
Babesia canis,  A. phagocytophilum,  L. infantum,
Bartonella henselae, and B. vinsonii ssp. berkhoffi antigens
were performed (3,7). Results are presented in Table 2.
Conclusions
Clinicopathologic abnormalities detected in these dogs
at initial examination, including acute onset of fever,
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USA; and ‡Clinica Veterinaria, Catania, Italylethargy, thrombocytopenia, anemia, mildly increased liver
enzyme activities and hypoalbuminemia, were very simi-
lar to abnormalities associated with spotted fever group
(SFG) rickettsioses in dogs and humans (1). In addition, R.
conorii DNAwas amplified in all dogs during the acute ill-
ness. Further evidence for R. conorii infection as a cause
of the associated clinical signs was provided by the subse-
quent failure to detect DNA in dogs 1 and 2, 1 week after
treatment with doxycycline and the rapid resolution of
clinical signs 2 days after initiating doxycycline therapy.
Clinical signs in dog 3 resolved in 4 days, while the dog
was receiving ceftriaxone, which has no known anti-rick-
ettsial efficacy (1). Spontaneous immune clearance of R.
conorii likely accounted for the resolution of clinical signs
in dog 3 (6).
The 4-fold increase in IgG antibody titers in dogs 2 and
3 supports seroconversion, which is consistent with an
acute R. conorii infection (11). Additionally, the initially
high IgM titer in dog 1 after the onset of illness compared
with a much lower IgM titer after 65 days is also support-
ive of an acute infection and is consistent with observa-
tions of human serologic test results (1). IgM titers rise
rapidly and then disappear by day 35 and 80 in dogs exper-
imentally infected with R. conorii and R. rickettsii, respec-
tively (6,11). However, high R. rickettsii IgM titers are
detected in dogs that do not seroconvert, based upon IgG
antibodies (11). Thus, the presence of IgM supports but
does not prove acute SFG infection in dogs.
Coinfection with A. phagocytophilum or B. burgdorferi
could have contributed to clinical signs observed in dog 1.
This dog had a low serum A. phagocytophilum titer 7 days
after initial examination and also seroconverted to B.
burgdorferi. A. phagocytophilum causes an acute febrile
illness in dogs and humans, similar to the findings
described here (12). B. burgdorferi does not cause clinical
signs in dogs until 60–150 days after experimental infec-
tion (13); therefore, despite seroconversion, the acute clin-
ical signs in dog 1 were not likely to have been related to
B. burgdorferi infection. Moreover, PCR amplification of
DNA from organisms other than R. conorii was not found
in any dog.
All dogs were intact, male, genetically unrelated
Yorkshire terriers. Although an increased risk for Rocky
Mountain spotted fever has not been reported in Yorkshire
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be more prone to clinical illness (14). Notably, this breed
seems to be at increased risk for Babesia canis infection
(15). Male dogs and men may be at increased risk for
infection and may develop more severe illness with R.
rickettsii and R. conorii (1,14), and male dogs are more
likely to be R. conorii seroreactive (3). It has been suggest-
ed that more severe illness may develop in English
springer spaniels with suspected phosphofructokinase
deficiency and persons with glucose 6-phosphate dehydro-
genase deficiency when infected with R. rickettsii and R.
conorii (1,14). Although inherited immunodeficiencies
have not been reported in Yorkshire terriers, and all dogs
were previously healthy, an inherited metabolic or
immunologic defect cannot be ruled out because specific
testing was not performed.
Although a metabolic or immunologic defect may be
necessary for illness to develop in dogs of various breeds
after R. conorii infection, other potential explanations can
be made for the discrepancy between high R. conorii sero-
prevalence rates among healthy dogs and lack of reports of
clinical illness. The high R. conorii seroprevalence in
healthy dog populations suggests that exposure to SFG
rickettsiae is common. However, the acute, nonspecific,
and potentially self-limiting nature of R. conorii infection,
combined with a low index of suspicion by regional veteri-
narians and a historical lack of specific diagnostic tech-
niques, may have precluded the prior association of
clinical signs with R. conorii infection in dogs. Further evi-
dence should be gathered regarding the extent to which R.
conorii causes clinical disease in dogs.
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